Literature DB >> 7909336

A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/alpha 1A-adrenergic affinity and a low potential for extrapyramidal effects.

A B Reitz1, D J Bennett, P S Blum, E E Codd, C A Maryanoff, M E Ortegon, M J Renzi, M K Scott, R P Shank, J L Vaught.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7909336     DOI： 10.1021/jm00034a003

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  2 in total

1.  Metabolic fate of the antipsychotic agent, mazapertine, in man--API-MS and MS/MS identification of urinary metabolites.

Authors:  Wu-Nan Wu; Linda A McKown; Allen B Reitz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jul-Sep       Impact factor: 2.441

2.  Hepatic metabolism of the new antipsychotic agent, mazapertine, in rat--API-MS/MS identification of metabolites.

Authors:  W N Wu; L A McKown; A B Reitz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Oct-Dec       Impact factor: 2.441
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.